Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Dec 5:3:178.
doi: 10.21037/jovs.2017.11.01. eCollection 2017.

DNA methylation analysis for the treatment of meningiomas

Julian L Gendreau  1 , Kevin K H Chow  2 , Eric S Sussman  2 , Aditya Iyer  2 , Arjun V Pendharkar  2 , Allen L Ho  2
Affiliations
Editorial

DNA methylation analysis for the treatment of meningiomas

Julian L Gendreau et al. J Vis Surg. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

  • DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D, Sturm D, Wirsching HG, Berghoff AS, Baumgarten P, Kratz A, Huang K, Wefers AK, Hovestadt V, Sill M, Ellis HP, Kurian KM, Okuducu AF, Jungk C, Drueschler K, Schick M, Bewerunge-Hudler M, Mawrin C, Seiz-Rosenhagen M, Ketter R, Simon M, Westphal M, Lamszus K, Becker A, Koch A, Schittenhelm J, Rushing EJ, Collins VP, Brehmer S, Chavez L, Platten M, Hänggi D, Unterberg A, Paulus W, Wick W, Pfister SM, Mittelbronn M, Preusser M, Herold-Mende C, Weller M, von Deimling A. Sahm F, et al. Lancet Oncol. 2017 May;18(5):682-694. doi: 10.1016/S1470-2045(17)30155-9. Epub 2017 Mar 15. Lancet Oncol. 2017. PMID: 28314689

References

    1. Sahm F, Schrimpf D, Stichel D, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 2017;18:682-94. 10.1016/S1470-2045(17)30155-9 - DOI - PubMed
    1. Bujko M, Machnicki MM, Grecka E, et al. Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype. World Neurosurg 2017;97:754.e1-6. 10.1016/j.wneu.2016.10.047 - DOI - PubMed
    1. Yuzawa S, Nishihara H, Yamaguchi S, et al. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system. Mod Pathol 2016;29:708-16. 10.1038/modpathol.2016.81 - DOI - PubMed
    1. van den Munckhof P, Christiaans I, Kenter SB, et al. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. Neurogenetics 2012;13:1-7. 10.1007/s10048-011-0300-y - DOI - PubMed
    1. Fukami S, Riemenschneider MJ, Kohno M, et al. Expression and gene doses changes of the p53-regulator PPM1D in meningiomas: a role in meningioma progression? Brain Tumor Pathol 2016;33:191-9. 10.1007/s10014-016-0252-x - DOI - PubMed

LinkOut - more resources